Physician profile
Heather E Tyndall
NPI 1740361369
$7,769.06
in general payments reported to CMS, 2019-2025
42 companies · $1,026 in 2025
The $1,026 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,276 · 2022: $1,719 · 2023: $2,058 · 2024: $1,689 · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,773.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,149.97 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $1,113.74 | 2021-2025 | Evenity, Prolia, Otezla |
| Novartis Pharmaceuticals Corporation | $722.78 | 2021-2025 | |
| Lilly USA, LLC | $671.17 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $520.24 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $506.36 | 2021-2025 | |
| Abbott Laboratories | $354.38 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| E.R. Squibb & Sons, L.L.C. | $290.24 | 2021-2024 | Eliquis, Camzyos |
| Pfizer INC. | $280.52 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $232.42 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Amarin Pharma, INC. | $209.29 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $150.00 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $126.28 | 2023-2025 | Rexulti |
| Esperion Therapeutics, INC. | $100.90 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $99.27 | 2021-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Tyndall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.